CORT Corcept Therapeutics Incorporat
$87.59▲ +0.53%
Healthcare
Other
After hours
$87.59▲ +0.00%
Oct 27, 4:17 PM ET
Volume 925.4K
Avg Volume (10D) 1.00M
Key Metrics & Fundamentals
Market Cap
$9.47B
P/E Ratio
194.6
Div Yield
0.00%
52W Range
28.66 - 126.38
% vs 50 MA
-23.22%
% vs 200 MA
18.28%
RSI-14
26.7
MACD Histogram
-3.6500
Beta (1Y vs SPY)
1.90
Free Cash Flow
$31.02M
Gross Rev
$256.15M
Gross Profit
$252.09M
EBITDA
$42.16M
COGS
$4.06M
Operating Exp
$210.79M
Operating Income
$41.30M
EBIT
$41.30M
Pretax Income
$45.93M
Net Income
$42.99M
EPS (Diluted)
0.36
Price & Volume History
Loading chart…
Recent News
Corcept Therapeutics to Announce Third Quarter Financial Results, Provide Corporate Update and Host Conference Call
Business Wire · Oct 27, 2026 4:05 PM ET
What Corcept Therapeutics Stock Positive Trial Results Mean For Shareholders
Simply Wall St. · Oct 26, 2026 7:31 PM ET
Corcept Therapeutics Says Trial of Lifyorli Combination Slows Ovarian Cancer Growth
MT Newswires · Oct 26, 2026 9:19 AM ET
Corcept Reports Positive Results from Phase 2 BELLA Trial of Lifyorli® Combined with Nab-Paclitaxel and Bevacizumab in Patients with Platinum-Resistant Ovarian Cancer
Business Wire · Oct 26, 2026 8:00 AM ET
Can Corcept Therapeutics Stock Rally 40% After This Dip?
Trefis · Oct 26, 2026 3:11 AM ET
Genmab stock surges 9% following positive phase 3 ovarian cancer trial results
Investing.com · Oct 23, 2026 12:44 PM ET
2 cash-producing stocks to research further and 1 we find risky
StockStory · Oct 22, 2026 1:33 PM ET
2026 ADA/EASD Consensus Report Recommends Screening for Hypercortisolism in Patients with Difficult-to-Control Type 2 Diabetes
Business Wire · Oct 20, 2026 4:00 PM ET
Can Lifyorli Aid Corcept's Long-Term Growth Prospects Beyond Korlym?
Zacks · Oct 19, 2026 8:50 AM ET
The Zacks Analyst Blog Highlights Ross Stores, Roku, APA, Corcept Therapeutics and Halozyme Therapeutics
Zacks · Oct 19, 2026 8:00 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See CORT's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.